The Intracellular Expression Pattern of the Human Papillomavirus Type 11 E1∧E4 Protein Correlates with Its Ability to Self Associate  by Bryan, Janine T. et al.
The Intracellular Expression Pattern of the Human Papillomavirus Type 11 E1^E4 Protein
Correlates with Its Ability to Self Associate
Janine T. Bryan,* Kenneth H. Fife,*,†,‡ and Darron R. Brown*,†,§,1
*Department of Microbiology and Immunology, †Department of Medicine, Divsion of Infectious Diseases, and ‡Department of Pathology, Indiana
University School of Medicine, and §Richard L. Roudebush Veterans Administration Medical Center, Indianapolis, Indiana 46202
Received August 5, 1997; returned to author for revision September 2, 1997; accepted November 19, 1997
The function of the human papillomavirus type 11 (HPV 11) E1^E4 spliced protein is not known. E1^E4 protein in
HPV-infected tissue is detected in the cytoplasm of differentiated epithelial cells and as immunoreactive bands correspond-
ing to potential monomers, dimers and trimers in immunoblots. The yeast two-hybrid system was employed to test for self
association of the HPV 11 E1^E4 protein. To confirm the results of the yeast two-hybrid experiments, coimmunofluorescence
studies of a green fluorescent fusion protein (GFP-E1^E4) and a T7 epitope-tagged E1^E4 protein were performed in C33a
keratinocytes. E1^E4 protein was shown to self associate in the yeast two-hybrid system, and this result was confirmed by
colocalization of GFP-E1^E4 and T7-E1^E4 proteins in keratinocytes. Analysis of E1^E4 mutants established that the
C-terminus was required for self association and that sequences in the N-terminus influenced the intracellular localization
of E1^E4 protein. The intracellular expression patterns of GFP-E1^E4 and GFP-E1^E4 mutants were correlated with E1^E4
binding in the yeast two-hybrid system. Those E1^E4 mutants that did not self associate in the yeast two-hybrid system were
detected as diffuse cellular fluorescence when expressed as GFP fusions. In contrast, GFP-E1^E4 was detected as a
perinuclear aggregate. All E1^E4 mutants capable of associating with E1^E4 in the yeast two-hybrid system were detected
as aggregates when expressed as GFP fusion proteins in keratinocytes. © 1998 Academic Press
INTRODUCTION
Human papillomaviruses (HPV) are small DNA viruses
which infect epithelial surfaces, causing a range of dis-
ease states (for review see Howley, 1996). Approximately
30 HPV types are regularly detected in genital tract
lesions. These lesions include genital warts, which are
characterized by epithelial proliferation and a low risk of
dysplastic abnormalities. Genital warts are most often
caused by HPV types 6a and 11 (Brown et al., 1993;
Gissmann et al., 1983; Pfister, 1987).
The most abundant viral mRNA detected in HPV 11-
infected genital wart tissue potentially encodes a 10-kDa
E1^E4 spliced gene product which joins a short segment
of open reading frame (ORF) E1 to ORF E4 (Chow et al.,
1987; Nasseri et al., 1987). The E1^E4 protein is poten-
tially encoded by two transcripts: the E1^E4,E5 and the
E1^E4^L1 transcripts. The E1^E4,E5 transcript contains
the sequences of the spliced E1^E4 ORF and the imme-
diate downstream E5a and E5b ORFs and is detected
early in HPV 11 infection and throughout the epithelial
layers (Stoler and Broker, 1986). The multiply spliced,
polycistronic E1^E4^L1 transcript encodes both the
E1^E4 protein and the L1 major capsid protein (Brown et
al., 1996; Chow et al., 1987; Rotenberg et al., 1989).
Despite the wide distribution of E1^E4-encoding tran-
scripts, the HPV 11 E1^E4 protein is detected only in the
cytoplasm of differentiated cells that are also expressing
L1 protein (Brown et al., 1994, 1995).
The function of the E1^E4 protein has not been deter-
mined. There is evidence that the E1^E4 proteins of HPV
types 1, 16, and 31b interact with the intermediate fila-
ment network when expressed in cells grown in culture
(Doorbar, 1991; Doorbar et al., 1991; Pray and Laimins,
1995; Roberts et al., 1993). However, in an analysis of
HPV 1-infected tissue, Doorbar et al., (1996) showed that
greater than 95% of the E4 protein exists as complexes
that do not include keratins. The complexes were pro-
posed to be E4 multimers. Immunoblots of tissue in-
fected with the cutaneous HPV types 1, 2, or 4 revealed
apparent doublets of the monomeric form and additional
higher molecular weight bands, potentially dimeric forms
of the E4 protein (Doorbar, 1989). In our laboratory, im-
munoblot analysis of HPV 11-infected tissue has re-
vealed a 10/11-kDa doublet, believed to be the mono-
meric form of E1^E4, and additional immunoreactive
bands at 18 and 29 kDa (Brown, 1988).
In this study the yeast two-hybrid system was used to
determined if the HPV 11 E1^E4 protein was capable of
self association. Mutant E1^E4 proteins were used in the
yeast two-hybrid assay to determine the critical regions
of the protein involved in E1^E4 self association. In
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addition, E1^E4 and E1^E4 mutant proteins were ex-
pressed as green fluorescent protein (GFP) fusion pro-
teins in C33a keratinocytes. Immunofluorescent studies
of T7 epitope-tagged E1^E4 coexpressed with the GFP-
E1^E4 fusion proteins were performed to confirm the
yeast two-hybrid self association results in keratino-
cytes. The intracellular expression pattern of the GFP-
E1^E4 fusion proteins expressed in keratinocytes was
analyzed to determine if a correlation could be drawn
between the intracellular expression pattern of E1^E4
and the E1^E4 mutant proteins and their ability to asso-
ciate with E1^E4 in the yeast two-hybrid system.
RESULTS
E1^E4 self association studies in the yeast two-hybrid
system
The colony lift b-galactosidase assay is a nonquanti-
tative assay in which a yeast colony color change to blue
is indicative of a protein:protein interaction between the
proteins fused to the GAL4 BD and the GAL4 AD. The
controls, SV40 large T-antigen as the prey and p53 or
laminC as bait, reacted as predicted in the b-galactosi-
dase assay, positive and negative, respectively (Table 1).
Additional controls demonstrated no evidence of intrinsic
E1^E4 transactivation potential nor the ability of the
E1^E4 protein to bind directly to GAL4 protein domains.
The complete E1^E4 protein cloned and expressed in
HF7c or SFY526 Saccharomyces cerevisiae as GAL4 BD
and GAL4 AD fusions resulted in a positive b-galactosi-
dase assay, confirming self association (Table 1). The
quantitative liquid culture b-galactosidase assay is an
indirect measure of the binding affinity of the interacting
proteins in the yeast two-hybrid system. The results of
the liquid culture b-galactosidase assay are expressed
as a percentage of the strength of E1^E4:E1^E4 binding
(Table 2).
Regional deletions of the E1^E4 protein consisting of
the N-terminal 60 aa (E1^E4D61–90), the C-terminal 58
aa (E1^E4D1–31), or the middle 28 aa (E1^E4 32–60)
TABLE 1
Results of E1^E4 Protein Interactions with E1^E4 Mutants and Controls in the Yeast Two-Hybrid System
GAL4 DNA binding domain
(BD) fusion proteina
GAL4 activation domain
(AD) fusion proteinb
Interactions in the yeast
two-hybrid system
determined by the
colony lift b-
galactosidase assayc
GAL4 BD GAL4 AD 2
GAL4 BD-p53 GAL4 AD-SV40 large T Ag 1
GAL4 BD-laminC GAL4 AD-SV40 large T Ag 2
GAL4 BD-E1^E4 GAL4 AD 2
GAL4 BD GAL4 AD-E1^E4 2
GAL4 BD-E1^E4 GAL4 AD-E1^E4 1
GAL4 BD-E1^E4 GAL4 AD-E1^E4D61–90 (N terminus) 2
GAL4 BD-E1^E4 GAL4 AD-E1^E4D1–31 (C terminus) 1
GAL4 BD-E1^E4 GAL4 AD-E1^E432–60 (Middle) 2
GAL4 BD-E1^E4D61–90 (N terminus) GAL4 AD-E1^E4 2
GAL4 BD-E1^E4D1–31 (C terminus) GAL4 AD-E1^E4 1
GAL4 BD-E1^E4 GAL4 AD-E1^E4D64–90 2
GAL4 BD-E1^E4 GAL4 AD-E1^E4D67–90 2
GAL4 BD-E1^E4 GAL4 AD-E1^E4D70–90 2
GAL4 BD-E1^E4 GAL4 AD-E1^E4D73–90 2
GAL4 BD-E1^E4 GAL4 AD-E1^E4D76–90 2
GAL4 BD-E1^E4 GAL4 AD-E1^E4D79–90 2
GAL4 BD-E1^E4 GAL4 AD-E1^E4D82–90 2
GAL4 BD-E1^E4 GAL4 AD-E1^E4D85–90 2
GAL4 BD-E1^E4 GAL4 AD-E1^E4D88–90 2
GAL4 BD-E1^E4 GAL4 AD-E1^E4R 3 L89 1
GAL4 BD-E1^E4 GAL4 AD-E1^E4D85–87 2
GAL4 BD-E1^E4 GAL4 AD-E1^E4Ala85–87 2
GAL4 BD-E1^E4 GAL4 AD-E1^E4D79–81 2
a S. cerevisiae were transformed with recombinant pGBT9 plasmids to produce GAL4 BD fusion proteins.
b S. cerevisiae were transformed with recombinant pGAD424 plasmids to produce GAL4 AD fusion proteins.
c Interactions between GAL4 BD and GAL4 AD fusion proteins in cotransformed S. cerevisiae determined by b-galactosidase activity in the colony
lift assay. (2) indicates no detectable interaction; (1) indicates a positive interaction between the proteins indicated by a blue color change.
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were expressed as GAL4 AD fusion or GAL4 BD fusion
proteins simultaneously with the complete 90-aa E1^E4
protein fused to the complementary GAL4 domain. The
N-terminal 60-aa and the middle 28-aa E1^E4 peptides
did not bind GAL4 domain fusions of E1^E4 protein
(Table 1). In contrast, the C-terminal 58-aa GAL4 domain
fusions were capable of interacting with the complemen-
tary complete E1^E4 GAL4 domain fusion protein, as
demonstrated by a positive colony lift b-galactosidase
assay. The results of the quantitative liquid culture b-ga-
lactosidase assay indicated that the strength of binding
was reduced to 31% when the amino terminus of the
protein was removed in the E1^E4D1–31 mutant (Table 2).
The E1^E4 C-terminal truncation, amino acid substitu-
tion, and internal deletion mutants were cloned as GAL4
AD fusions and coexpressed with complete E1^E4 as a
GAL4 BD fusion protein (Fig. 1). None of the C-terminal
truncation mutants interacted with the GAL4 BD-E1^E4
fusion protein (Table 1). Removal of just three amino
acids from the C-terminus was sufficient to abrogate
binding to GAL4 BD-E1^E4. In addition, an interaction
between GAL4 BD-E1^E4 and either of the two mutants
with internal three amino acid deletions, E1^E4D85–87
and E1^E4D79–81, was not detectable by the colony lift
b-galactosidase assay. The quantitative liquid culture
b-galactosidase assay revealed that the E1^E4D79–81
mutant was capable of binding E1^E4, although the
strength of binding was only 5% of full-length E1^E4:
E1^E4 binding (Table 2). Substituting three alanines at
amino acid positions 85–87 did not reconstitute a posi-
tive interaction with the GAL4 BD-E1^E4 fusion protein.
The substitution mutant in which the arginine at position
89 was replaced with leucine was capable of interacting
with complete E1^E4 as a GAL4 BD fusion protein. The
strength of this interaction was 73% of full-length E1^E4:
E1^E4 binding (Table 2).
Expression of E1^E4 fusion proteins in eukaryotic
cells
Immunoblot analysis of transiently transfected COS-7
cells demonstrated expression of GFP, GFP-E1^E4, and
the GFP-E1^E4 mutant fusion proteins at the predicted
molecular weights (Fig. 2). COS-7 cells were used for this
assay because of the ease in high-level transfection and
expression. GFP-E1^E4D88–90 consistently migrated
slightly slower than predicted, possibly due to a confor-
mational change in the protein as a result of the three
amino acid C-terminal deletion.
To correlate the pattern of intracellular E1^E4 protein
expression in keratinocytes with self association poten-
tial, C33a cells were transiently transfected with pEGFP-
C1, pEGFP-C1-E1^E4, or the pEGFP-C1-E1^E4 mutant
plasmids. Nonfused GFP showed uniform fluorescence
throughout the entire cell (Fig. 3a). GFP-E1^E4 protein
was detected as a discrete, dense, perinuclear aggre-
gate with low-intensity, diffuse fluorescence in the cyto-
plasm (Fig. 3b). Cells expressing the GFP-E1^E4D61–90
(N-terminus) resembled nonfused GFP (Fig. 3c), with no
visible aggregate formation, only diffuse fluorescence
throughout the cell. In contrast, the GFP-E1^E4D1–31
(C-terminus) was detected as multiple small, dense, ag-
gregates in the nucleus (Fig. 3d). The cytoplasmic loca-
tion of the GFP-E1^E4 protein and the nuclear localiza-
tion of the GFP-E1^E4D1–31 protein were confirmed by
confocal imaging (Fig. 4).
Expression of the deletion mutant with the last three
amino acids removed, GFP-E1^E4D88–90, resulted in
cells fluorescing in a pattern similar to nonfused GFP
(Fig. 3h). The internal deletion mutant E1^E4D85–87 and
the alanine substitution mutant E1^E4Ala85–87 did not
associate with the GAL4 BD-E1^E4 fusion protein in the
yeast two-hybrid system. When expressed as GFP fusion
TABLE 2
Intracellular Expression Pattern of GFP-E1^E4 and the Results of the Yeast Two-Hybrid b-Galactosidase Assay
E1^E4 proteins and GFP control
Fluorescence pattern of GFP-E1^E4 fusion
proteins and GFP controla
Interactions in the yeast two-hybrid system
determined by the liquid culture b-galactosidase
assay with ONPG substrateb
GFP Diffuse throughout the cell ndc
Complete E1^E4 Large, dense perinuclear aggregate 100%
E1^E4 D61–90 (N terminus) Diffuse throughout the cell 1%
E1^E4 D1–31 (C terminus) Multiple small nuclear aggregates 31%
E1^E4 D88–90 Diffuse throughout the cell 1%
E1^E4 R 3 L89 Large, dense perinuclear aggregate 73%
E1^E4 D85–87 Diffuse throughout the cell 1%
E1^E4 Ala85–87 Diffuse throughout the cell 1%
E1^E4 D79–81 Small aggregates throughout the cell 5%
a Transient transfection assay of C33a cells with pEGFP-C1-E1^E4 and E1^E4 mutant recombinant plasmids.
b Interactions in the yeast two-hybrid system were determined by the expressed b-galactosidase activity. The results of the quantitative liquid
culture b-galactosidase assay are presented as a percentage of the positive GAL4 BD-E1^E4:GAL4 AD-E1^E4 interaction.
c Not done.
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proteins in C33a cells, the GFP-E1^E4D85–87 and GFP-
E1^E4Ala85–87 proteins appeared similar to the GFP-
E1^E4D88–90 protein and nonfused GFP, with diffuse
fluorescence and no visible aggregate formation (Figs. 3i
and 3f). The GFP-E1^E4D79–81 protein differed from both
nonfused GFP and GFP-E1^E4, with multiple small ag-
gregates detected throughout the cell (Fig. 3g). This
mutant was capable of binding E1^E4 in the yeast two-
hybrid system, although at a very reduced level as was
demonstrated by b-galactosidase activity in the liquid
culture assay (Table 2).
In contrast with the above GFP-E1^E4 mutant proteins,
the GFP-E1^E4 R 3 L89 substitution mutant was de-
tected as a dense perinuclear aggregate indistinguish-
able from GFP-E1^E4 (Fig. 3e). As described above, this
mutant did associate with the GAL4 BD-E1^E4 fusion
protein in the yeast two-hybrid system. A comparison of
the intracellular expression patterns of the GFP fusion
proteins and the corresponding yeast two-hybrid assays
are summarized in Table 2.
The intracellular expression patterns of T7E1^E4 pro-
tein and GFP-E1^E4 protein in C33a cells were very
similar (Fig. 5). GFP-E1^E4 was predominantly detected
as a perinuclear aggregate or aggregates in C33a cells.
Similarly, the T7E1^E4 protein was predominantly de-
FIG. 1. Schematic representation of the HPV 11 E1^E4 protein and mutants. The numbers 1, 79, and 90 at the top of the figure indicate amino acid
(aa) residues. The sequence of the C-terminal 12 amino acids in single letter aa code are indicated above the E1^E4 protein in parentheses. The
names of the proteins are to the left. The ‘‘D’’ symbol indicates an E1^E4 protein with a deletion of the amino acids corresponding to the numbers
following the symbol. For example, E1^E4D1–31 is an E1^E4 mutant containing amino acids 32 through 90. E1^E4 32–60 is a protein with deletions
at both the N-terminus and the C-terminus, containing only amino acids 32 through 60. The white boxes represent the substituted amino acids in
E1^E4 R3 L89 and E1^E4 Ala85–87. The arginine at amino acid position 89 was replaced with a leucine residue in E1^E4 R3 L89 and amino acids
at positions 85 through 87 were replaced with alanine residues in E1^E4 Ala85–87. The gaps between black boxes indicate the internal amino acids
deleted in E1^E4D85–87 and E1^E4D79–81 proteins.
FIG. 2. Immunoblot of transiently transfected COS-7 cells expressing
GFP fusion proteins. COS-7 cells expressing: lane 1, mock, no GFP;
lane 2, nonfused GFP; lane 3, GFP-E1^E4; lane 4, GFP-E1^E4D61–90;
lane 5, GFP-E1^E4D1–31; lane 6, GFP-E1^E4D88–90; lane 7, GFP-
E1^E4R 3 L89; lane 8, GFP-E1^E4D85–87; lane 9, GFP-E1^E4Ala85–
87; lane 10, GFP-E1^E4D79–81. Molecular weight markers in kDa are
shown to the left.
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tected in a perinuclear location, generally as multiple
aggregates concentrated on one side of the nucleus.
Although GFP is approximately three times the size of
HPV 11 E1^E4, the GFP portion of the fusion appeared to
have little effect on the intracellular localization pattern of
E1^E4 in C33a cells.
Colocalization of T7E1^E4 and GFP-E1^E4 fusion pro-
teins in C33a cells was examined by double-image pho-
tography. T7E1^E4 and GFP-E1^E4 proteins coex-
pressed in C33a cells revealed an identical localization
pattern (Figs. 6a, 6b, and 6c). As indicated above, the
GFP-E1^E4D1–31 mutant localized to nucleus (Fig. 4b)
FIG. 3. Fluorescent microscopy of C33a keratinocytes expressing GFP or GFP-E1^E4 fusion proteins. C33a cells expressing: (a) nonfused GFP; (b)
GFP-E1^E4; (c) GFP-E1^E4D61–90; (d) GFP-E1^E4D1–31; (e) GFP-E1^E4R3 L89; (f) GFP-E1^E4Ala85–87; (g) GFP-E1^E4D79–81; (h) GFP-E1^E4D88–
90; (i) GFP-E1^E4D85–87. The peripheries of the nuclei in b, d, and e are indicated by arrowheads. Original magnification, 4003.
FIG. 4. Confocal microscopy image of transiently transfected C33a keratinocytes expressing: (a) GFP-E1^E4; (b) GFP-E1^E4D1–31 (C-terminal 58
aa). The peripheries of the nuclei are indicated by arrows.
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and the T7E1^E4 protein was expressed in the cyto-
plasm as perinuclear aggregates (Fig. 5b). When GFP-
E1^E4D1–31 was coexpressed with T7E1^E4, T7E1^E4
was detected exclusively in the nucleus (Figs. 6d, 6e, and
6f). In contrast, the E1^E4D88–90 mutant, which does not
associate with E1^E4 in the yeast two-hybrid system,
was detected as diffuse fluorescence throughout the cell
when expressed as a GFP fusion protein (Fig. 3h). This
pattern of fluorescence remained unchanged when GFP-
E1^E4D88–90 was coexpressed with T7E1^E4 (Fig. 6g)
and T7E1^E4 appeared as bright perinuclear fluores-
cence (Fig. 6h). Double-image photography revealed dif-
ferent intracellular localization patterns of the T7E1^E4
and GFP-E1^E4D88–90 proteins (Fig. 6i).
DISCUSSION
The function of the E1^E4 protein remains to be de-
termined, although increasing evidence suggests that
this cytoplasmic protein, which is detected only in termi-
nally differentiated cells, may have a role in the last
stages of the HPV life cycle. Several basic features of
E1^E4 proteins appear to be relatively conserved among
HPV types, including cutaneous and genital types. These
features include a high proline content, a conserved
N-terminal sequence (LLXLL), and the potential capacity
to form oligomeric complexes. Immunoblot analysis of
HPV 11-infected tissue with anti-E1^E4 serum has re-
vealed a doublet at 10/11 kDa and additional 18- and
29-kDa proteins (Brown, 1988). The 10- and 11-kDa dou-
blet may represent monomeric forms of the E1^E4 pro-
tein, while the larger species may represent dimers and
trimers. In this report, we have confirmed the ability of
HPV 11 E1^E4 to self associate.
The yeast two-hybrid system directly assays protein:
protein interactions (Bartel et al., 1993; Fields and Song,
1989). Doorbar et al., found that the HPV 1 E1^E4 protein
could self associate and that the C-terminus was impor-
tant for multimerization (Doorbar, 1988; Doorbar et al.,
1996). Similarly, we found that the C-terminus was nec-
essary for self association of HPV 11 E1^E4. We further
attempted to define the regions or amino acid residues
involved in HPV 11 E1^E4:E1^E4 binding by a more
detailed mutational analysis. We found that changing or
deleting just three amino acids in any of several loca-
tions within the C-terminus was sufficient to abrogate, or
severely limit, binding. Only the C-terminal mutant in
which the charged 89th amino acid, arginine, was sub-
stituted with a leucine residue (E1^E4 R3 L89) retained
the ability to associate with E1^E4 at a high level. Be-
cause deletion of the C-terminal three amino acids,
leucine-arginine-leucine, eliminated the ability of E1^E4
to self associate, we conclude that either one or both of
the leucine residues is involved in E1^E4 self associa-
tion or that truncation of the protein altered the confor-
mation and prevented binding.
The yeast two-hybrid system cannot distinguish be-
tween loss of protein:protein binding due to a change in
protein conformation versus loss of protein:protein bind-
ing due to the omission of a necessary amino acid
(Bartel et al., 1993; Fields and Song, 1989; Keegan et al.,
1986). Although we were unable to establish the exact
mechanism of HPV 11 E1^E4 self association, the three
amino acid internal deletion mutant E1^E4D85–87 did
not interact with E1^E4. Reconstructing the protein to the
original length with alanine residues substituted at
amino acid positions 85–87, E1^E4Ala85–87, did not re-
FIG. 5. Fluorescent microscopy of transiently transfected C33a keratinocytes with pEGFP-C1-E1^E4 or pcDNA3.1(1)-T7E1^E4 plasmids. (a) Direct
fluorescence of GFP-E1^E4; (b) indirect immunofluorescence to detect the T7E1^E4 protein. The primary antibody was a mouse monoclonal antibody
against the T7 epitope; the secondary antibody was a anti-mouse fluoresceine conjugate. Arrowheads indicate the peripheries of nuclei. Original
magnification, 6003.
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store the ability of the protein to interact with E1^E4,
suggesting that length alone is not sufficient.
In a recent review by Jones and Thornton (1996), the
structural properties of the interface surface of 59 pro-
tein:protein complexes were compared. It was con-
cluded that no single parameter absolutely differentiates
the protein:protein interface; however, a striking correla-
tion for accessible surface area was observed. In dimer
formation, the interfaces tend to protrude from the sur-
face, reflecting the fact that the side chains from one
monomer extend from the surface to interact with the
other half of the dimer. Sixteen of the C-terminal 32
amino acids of HPV 11 E1^E4 are either a serine or a
threonine. Therefore, HPV 11 E1^E4 protein contains a
great potential for surface extension and hydrogen bond-
ing through the amino acids in the C-terminus.
The interiors of proteins are primarily composed of
hydrophobic amino acid residues. The C-terminus of the
genital HPV types 11 and 16 E1^E4 proteins are highly
conserved (HPV 11 E1^E4 aa 74–90 ITtsTKEGtTVtVqLrl;
HPV 16 E1^E4 aa 76–92 LTahTKDGlTViVtLhp; conserved
residues in boldface capital letters). The nonconserved
amino acids of HPV 11 E1^E4 contain more polar resi-
dues than those in HPV 16 E1^E4. Interestingly, we have
found that HPV 16 E1^E4 protein does not self associate
in the yeast two-hybrid system, nor could HPV 11 E1^E4
bind HPV 16 E1^E4 (our unpublished results). It can be
hypothesized that the common residues are not directly
involved in the self association interaction. However, the
HPV 11 E1^E4 hydrophobic residues may come together
in a specific conformation in the interior of the protein,
excluding the nonconserved polar residues, thereby pre-
senting them at the exposed interface surface.
Using GFP-E1^E4 fusion proteins expressed in kerati-
nocytes, we correlated E1^E4 self association with the
pattern of intracellular expression. GFP contains no in-
trinsic intracellular localization signal (Chalfie et al.,
1994; Cubitt et al., 1995; Ormo¨) et al., 1996). Nonfused
GFP expressed in C33a keratinocytes was detected as
uniform, diffuse fluorescence throughout the cell,
whereas GFP-E1^E4 was detected as a distinct, dense
perinuclear aggregate. We therefore believe that the cy-
toplasmic, perinuclear localization of the GFP-E1^E4 fu-
sion protein is specifically due to sequences in the
FIG. 6. Fluorescent microscopy of C33a keratinocytes co-transfected with plasmids expressing: row 1, GFP-E1^E4 and T7E1^E4 proteins; row 2,
GFP-E1^E4D1–31 and T7E1^E4 proteins; row 3, GFP-E1^E4D88–90 and T7E1^E4 proteins. (a, d, and g) Detection of GFP-E1^E4 fusion proteins by
direct fluorescence at 488-nm wavelength; (b, e, and h) Detection of T7E1^E4 by indirect immunofluorescence with a primary mouse monoclonal
antibody against the T7 epitope and a secondary anti-mouse rhodamine conjugate at 590-nm wavelength; (c, f, and i) Double-image photography at
488- and 590-nm wavelengths for simultaneous detection of T7E1^E4 and the GFP-E1^E4 fusion proteins. Open arrowheads indicate the peripheries
of nuclei. Solid arrowheads in row 2 indicate the peripheries of the cells. Original magnification, 6003.
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E1^E4 portion of the fusion protein. Although GFP is
approximately three times the molecular weight of
E1^E4, the intracellular localization and expression pat-
tern of GFP-E1^E4 in C33a cells appears very similar to
the T7E1^E4 protein, which contains just 11 aa fused to
the N-terminus of E1^E4. Mutating the C-terminus of the
GFP-E1^E4 protein resulted in no perinuclear aggregate
formation, except in the case of the one mutant, GFP-
E1^E4 R3 L89, which strongly associated with E1^E4 in
the yeast two-hybrid system. In this case, the fluores-
cence pattern was indistinguishable from that of GFP-
E1^E4. The pattern of intracellular expression of the
mutants which did not interact with E1^E4 in the yeast
two-hybrid system were generally diffuse, similar to non-
fused GFP. Interestingly, the intracellular expression pat-
tern of the E1^E4D79–81 mutant was not strictly diffuse,
but contained small punctuate areas of bright fluores-
cence randomly scattered throughout the cell. This mu-
tant bound E1^E4 protein and transactivated lacZ at a
very low level in the yeast two-hybrid system. The re-
duced strength of GFP-E1^E4D79–81 self binding may be
capable of supporting formation of small aggregates. A
higher ordered complex may be required to associate
with cellular factors to achieve perinuclear localization in
C33a cells.
Removing the N-terminus of the E1^E4 protein shifted
the expression of GFP-E1^E4D1–31 to the nucleus as
multiple small aggregates. These data suggest that de-
letion of the first 31 amino acids of the HPV 11 E1^E4
protein either unmasked a nuclear localization signal in
the C-terminal two-thirds of the protein or removed a
sequence necessary for cytoplasmic expression. Rogel-
Gaillard et al., (1992) observed a similar change in the
localization of the HPV 1 E4 protein when the N-terminal
end was altered. E1^E4D1–31 was capable of binding
E1^E4 in the yeast two-hybrid system. Coexpression of
T7E1^E4 and GFP-E1^E4D1–31 in C33a cells resulted in
colocalization of both proteins to the nucleus. This ob-
servation strongly suggests a physical interaction be-
tween T7E1^E4 and the mutant, GFP-E1^E4D1–31, and
that the signal for nuclear localization is dominant over
that for cytoplasmic retention.
In contrast to the HPV 1 E1^E4 protein, our unpub-
lished studies show that the HPV 11 E1^E4 protein is not
soluble in buffers free of strong detergents or reducing
agents. We have been unsuccessful in our attempts to
utilize traditional biochemical methods such as coimmu-
noprecipitation to confirm self association of HPV 11
E1^E4 protein using extracts from tissues or cells. Ex-
traction of HPV 11 E1^E4 protein expressed in eukaryotic
cells either naturally in infected tissue or by transient
transfection of keratinocyte cell lines has required a high
concentration of detergents and denaturing agents (our
unpublished data). These conditions are incompatible
with antibody:protein and most other protein:protein in-
teractions which are the basis of coimmunoprecipitation
and pull down assays. Therefore, colocalization within
cells was used to demonstrate protein:protein interac-
tions, rather than immunoprecipitation methods. Colocal-
ization of the differentially tagged E1^E4 proteins, GFP-
E1^E4 and T7E1^E4, expressed in C33a cells was
consistent with the results of the yeast two-hybrid exper-
iments. Furthermore, the ability of the mutant GFP-
E1^E4D1–31 fusion protein to colocalize with T7E1^E4 in
the nucleus provides further support for a physical as-
sociation between the proteins.
The host cell and differentiation state have been
shown to significantly affect the distribution of E1^E4
proteins of other HPV types (Pray and Laimins, 1995). For
HPV 11-infected tissue, the E1^E4 protein is detected in
the cytoplasm near the cell membrane, exclusively in
differentiated epithelial cells. In the current study the
GFP-E1^E4 fusion protein was detected as a perinuclear
aggregate in C33a cervical carcinoma cells. These cells
were grown in monolayer culture and are considered to
be basal-like cells. Epithelial cell differentiation involves
a sequential induction and repression of a large number
of gene products including proteins involved in DNA
replication and structural proteins including cytokeratins.
It is likely that the E1^E4 protein functions by associating
with cellular proteins. E1^E4-binding proteins in C33a
cells may differ from those expressed in differentiated
epithelial cells, which may partially explain the intracel-
lular localization differences noted between tissue and
C33a cells.
In vitro studies of E1^E4 protein of other HPV types
suggest that E1^E4 may interact with cytokeratins, al-
though the in vivo significance of this observation is in
question (Doorbar, 1991; Doorbar et al., 1991, 1996; Pray
and Laimins, 1995; Roberts et al., 1993). The focus of our
study was to specifically examine HPV 11 E1^E4 protein
self association, rather than E1^E4 interactions with cel-
lular proteins. We are currently examining E1^E4 inter-
actions with proteins found in differentiated tissues
rather than in undifferentiated cells.
In summary, the HPV 11 E1^E4 protein was found to
self associate in the yeast two-hybrid system, and the
C-terminus was necessary for this function. Mutational
analysis suggests that residues in the C-terminus are
involved in determining the conformation required for
self association. HPV 11 E1^E4 self association was
confirmed by colocalization of GFP-E1^E4 and T7E1^E4
proteins expressed in C33a cells. A correlation was ob-
served between E1^E4 self association and the intracel-
lular distribution of the GFP-E1^E4 fusion proteins in
C33a cells. Multimerization of HPV 11 E1^E4 appears to
be an intrinsic feature of the protein and may be neces-
sary for proper E1^E4 function. Continuing studies will
examine the ability of E1^E4 and E1^E4 mutants to as-
sociate with keratinocyte proteins.
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MATERIALS AND METHODS
Cloning E1^E4 Sequences
HPV 11 E1^E4 sequences were excised from pUC19-
E1^E4(11) (Brown et al., 1994) and cloned into the GAL4
DNA binding domain vector, pGBT9 (Clontech, Palo Alto,
CA), at the BamHI/SalI sites. DH5a Escherichia coli cells
were transformed and colonies screened for the pres-
ence of plasmid DNA with an E1^E4 insert. Exact in-
frame cloning was confirmed by DNA sequencing using
the chain-termination method (Sanger et al., 1977). In a
similar manner, E1^E4 sequences were cloned into the
GAL4 activation domain vector, pGAD424 (Clontech).
For intracellular expression of the GFP-E1^E4 fusion
protein, HPV 11 E1^E4 sequences were subcloned into
the pEGFP-C1 vector (Clontech) at the SacI/SalI sites.
This vector contains the Aequorea victoria jellyfish green
fluorescent protein gene (Chalfie et al., 1994), which has
been mutated to enhance fluorescent emission at 510
nm (Cormack et al., 1996) and is driven by the CMV
immediate-early promoter. In-frame cloning of the GFP-
E1^E4 fusion was confirmed by DNA sequencing.
The HPV 11 E1^E4 protein was also expressed as a T7
epitope-tagged fusion protein. The T7 epitope chosen is
an 11 amino acid sequence, MASMTGGQQMG, from the
natural N-terminal end of the T7 major capsid protein,
against which a highly reactive monoclonal has been
raised (Novagen, Madison, WI). A 59 T7E1^E4 primer
containing an extension sequence encoding the T7
epitope (59 GCT AGC ATG GCT AGC ATG ACT GGT GGA
CAG CAA ATG GGT ATG GCG GAC GAT TCA GCA CTG
TAC GAG 39) was used with the 39 EcoE1^E4B primer (59
CCC CGA ATT CCT ATA GGC GTA GCT GCA CTG 39) to
amplify T7E1^E4 sequences by polymerase chain reac-
tion (PCR) (Saiki et al., 1988). The reaction consisted of
40 cycles of 94°C 1-min denaturing, 52°C 1-min anneal-
ing, and 72°C 1-min extension. The amplified product
was ligated directly to pCR3.1 (Invitrogen, Carlsbad, CA)
and TOP10F9 E. coli cells transformed. DNA sequencing
confirmed proper amplification and incorporation of the
T7 sequences at the 59 end of E1^E4. T7E1^E4 was
excised from pCR3.1 with XhoI/HindIII and ligated to
produce the pcDNA3.1(1)-T7E1^E4 recombinant plas-
mid.
PCR was utilized to produce GAL4 DNA binding do-
main and GAL4 activation domain fusions with the N-
terminal 60 amino acids (aa), the C-terminal 58 aa, and
the middle 28 aa of E1^E4 (Fig. 1). Amplified products of
the appropriate size were ligated directly into pCR3.1
(Invitrogen) and subcloned into pGBT9 and pGAD424 at
the BamHI/SalI sites. Sequence analysis confirmed
proper amplification and in-frame GAL4 DNA binding
domain and GAL4 activation domain fusions with the
E1^E4 sequences. To produce GFP fusion proteins, the
N-terminal and C-terminal E1^E4 sequences were sub-
cloned into pEGFP-C1 at the SacI/SalI sites.
To determine if specific amino acid sequences were
needed for E1^E4 self association, C-terminal E1^E4
deletion mutants were created by PCR. Nine 39 primers
were designed to allow amplification of nucleotides
1–189 to 1–261 of E1^E4 in a systematic stepwise man-
ner (Fig. 1). Each consecutive 39 primer allowed amplifi-
cation of an additional nine nucleotides. The primers
were engineered with TAG stop sequences in-frame and
SalI extensions. The amplified products were ligated
directly to pCR3.1 and TOP10F9 cells transformed. Colo-
nies were screened for those containing the pCR3.1
vector with an appropriately sized insert. Sequencing
confirmed the 39 truncations of the E1^E4 DNA. The
E1^E4 39 truncation fragments were excised from pCR3.1
and ligated to pGAD424 at the BamHI/SalI sites. Com-
plete DNA sequencing of all cloned PCR products was
performed to confirm proper sequence amplification and
in-frame cloning.
To further determine the mechanisms of self associa-
tion, E1^E4 substitution and internal deletion mutants
were created by PCR. The last nine amino acids of E1^E4
are TTVTVQLRL. Two substitution mutants and two in-
ternal deletion mutants were created. These are desig-
nated E1^E4R 3 L89, E1^E4Ala85–87, E1^E4D85–87,
and E1^E4D79–81, respectively (Fig. 1). Amplification
with the 39 primer (59 GTG GAC CTA TAG GAG TAG CTG
CAC 39) containing the TAG stop codon and SalI site
extension allowed substitution of an adenine (in bold-
face) in place of a thymine, altering the sequence of the
89th amino acid encoded from an arginine to a leucine in
the E1^E4R3 L89 mutant. The last nine amino acids of
the E1^E4R 3 L89 mutant protein are TTVTVQLLL. Am-
plification with the 39 primer (59 GTC GAC CTA TAG GCG
TAG CGC CGC TGC GAC AGT TGT TCC TTC TTT 39)
allowed the introduction of four point mutations (in bold-
face), altering the sequence to encode three alanines (A)
and resulting in the sequence TTVAAALRL for
E1^E4Ala85–87. The internal deletion, E1^E4D85–87,
was created using the 39 primer (59 GTC GAC CTA TAG
GCG TAG/GAC AGT TGT TCC TTC TTT GGT 39) contain-
ing a SalI site extension. The nine nucleotides encoding
amino acids 85–87, TVQ, were removed, leaving the last
six amino acids as TTVLRL. In a similar manner,
E1^E4D79–81 was created using the 39 primer (59 GTC
GAC CTA TAG GCG TAG CTG CAC TGT GAC AGT TGT/
GGT GCT TGT TGT AAT TGT CAG 39), which effectively
removed the sequences encoding amino acids 79–81.
PCR products were ligated directly to pCR3.1 and sub-
cloned into pGAD424 and pEGFP-C1 to produce GAL4
activation domain and GFP fusion proteins, respectively.
Complete DNA sequencing confirmed proper amplifica-
tion and in-frame cloning. An additional clone, the C-
terminal truncation which removed only the last three
amino acids of E1^E4, designated E1^E4D88–90, was
also subcloned into pEGFP-C1.
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E1^E4 self association studies in the yeast two-hybrid
system
The yeast two-hybrid system was applied to determine
whether the E1^E4 protein could specifically associate
with another E1^E4 molecule. The HPV 11 E1^E4 cDNA
was cloned into the pGBT9 and pGAD424 vectors which
contain the GAL4 transcription factor DNA binding do-
main (BD) and the activation domain (AD), respectively
(Bartel et al., 1993). The BD fusion binds a GAL4-respon-
sive element on the DNA and acts as the bait. The prey,
the protein fused to the AD, is assayed for its ability to
bind to the bait, bringing the GAL4 BD and GAL4 AD
together, which transactivates a downstream gene
(Fields and Song, 1989; Keegan et al., 1986). HF7c and
SFY526 strains of S. cerevisiae have been engineered to
contain the lacZ gene with GAL4 responsive elements
upstream (Bartel et al., 1993; Feilotter et al., 1994). S.
cerevisiae were made competent by the lithium acetate
method and transformed with 100 ng of each pGBT9-
E1^E4 and pGAD424-E1^E4 plasmids and plated onto
selective media as described by Clontech (Matchmaker
Two-Hybrid System, Clontech, Palo Alto, CA). Non-fused
GAL4 domain vectors were transformed in combination
with both GAL4 domain E1^E4 fusion constructs as con-
trols for nonspecific transactivation. In addition, plasmids
encoding GAL4 BD-p53 as bait and GAL4 AD-SV40 large
T antigen as prey were transformed as a positive control
for GAL4 transactivation, and GAL4 BD-laminC as bait
with GAL4 AD-SV40 large T antigen as prey were trans-
formed as a negative control (supplied by Clontech).
To demonstrate an interaction between the fusion pro-
teins, a colony lift b-galactosidase filter assay was per-
formed. A Whatman 5 filter was placed over the colonies,
lifted, and quick frozen in liquid nitrogen for 10 s. An
identical filter was saturated with Z buffer/X-gal solution
(Z buffer, 60 mM Na2HPO4 z 7H2O, 40 mM NaH2PO4 z
H2O, 10 mM KCl, 1mM MgSO4 z 7H2O; and X-gal solution,
20 mg X-gal/ml N,N-dimethylformamide used at a final
concentration of 0.3 mg/ml) plus 40 mM b-mercaptoetha-
nol. After the first filter returned to room temperature, it
was placed colony side up on top of the saturated filter
and incubated in a sealed petri dish at room temperature
for 18 h. Colonies were inspected for blue color formation
indicative of GAL4 BD fusion/AD fusion interactions.
The affinity of binding of GAL4 AD-E1^E4 and a subset
of the GAL4 AD-E1^E4 mutants with GAL4 BD-E1^E4
was indirectly quantitated by the liquid culture b-galac-
tosidase assay with ONPG (o-nitrophenyl b-D-galactopy-
ranoside) as substrate as described by Clontech (Match-
maker Two-Hybrid System). Briefly, three individual
colonies from each cotransformed yeast plate were in-
oculated in 5 ml complete synthetic liquid medium with-
out leucine or tryptophan plus 2% dextrose, shaking at
220 rpm for 18 h at 30°C. The yeast were subcultured
and grown to mid-log phase and OD600 recorded. Each
culture was assayed in duplicate. One and a half millili-
ters of cells was pelleted by centrifugation, washed, and
suspended in Z buffer. The cell suspension was quick
frozen in liquid nitrogen and rapidly thawed in a 37°C
water bath. Seven volumes of Z buffer with 38 mM b-mer-
captoethanol was added along with 640 mg ONPG in Z
buffer. The tubes were incubated at 30°C and the
elapsed time recorded in minutes. The reaction was
stopped with the addition of 0.4 vol 1 M Na2CO3. The
tubes were centrifuged to pellet debris and the OD420 of
the supernates determined by spectrophotometry. b-ga-
lactosidase units were calculated using the equation
b-galactosidase units 5 1000 3 OD420/(t 3 V 3 OD600),
where t is elapsed time in minutes and V is 0.1 ml 3
concentration factor. In total, six reactions were per-
formed for each two-hybrid interaction. The b-galactosi-
dase units for each interaction were averaged and ex-
pressed as a percentage of the positive control
interaction GAL4 BD-E1^E4:GAL4 AD-E1^E4 (Table 2).
The results of GAL4 fusion interactions in HF7c cells
were confirmed by transforming the plasmids into a
second strain of S. cerevisiae, SFY526. This yeast strain
has been engineered to contain the lacZ gene under the
control of a different promoter than that found in HF7c,
with a separate arrangement of GAL4 responsive ele-
ments. Demonstration of b-galactosidase activity in both
yeast strains indicates that transcription by GAL4 trans-
activation is due to a specific interaction between the
GAL4 BD and GAL4 AD fusion proteins.
To determine which portion of the E1^E4 molecule
was involved in oligomerization, pGBT9-E1^E4 contain-
ing the entire E1^E4 molecule was cotransformed into S.
cerevisiae with plasmids encoding GAL4 AD-E1^E4 re-
gional truncations, C-terminal deletions, and substitu-
tions or internal deletion mutants. SFY526 cells were
used in all cases, as the promoter driving lacZ expres-
sion is stronger than the promoter in HF7c, allowing for
optimal detection of b-galactosidase activity (Bartel et al.,
1993; Feilotter et al., 1994).
Expression of E1^E4 fusion proteins in eukaryotic
cells
Immunoblot analysis was performed to verify expres-
sion of the GFP-E1^E4 fusion proteins. COS-7 cells in
25-cm2 tissue culture flasks were transfected using the
DOTAP liposomal transfection reagent as described by
the manufacturer (Boehringer Mannheim, Indianapolis,
IN). Briefly, 10 mg of plasmid DNA was combined with 30
mg of DOTAP in 13 PBS, pH 7.4, in a final volume of 150
ml. After 15 min, 4 ml of complete medium (DMEM high
glucose medium containing 10% fetal bovine serum, 1000
U/ml penicillin, 1 mg/ml streptomycin, and 2.5 ng/ml
amphotericin B) was added and gently pipetted to mix.
The medium on the COS-7 cells was aspirated and the
transfection solution applied. After 3 h at 37°C and 5%
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CO2, the transfection solution was aspirated and 4 ml of
complete media applied to the cells. The cells were
allowed to grow at 37°C and 5% CO2 for 48 h before
harvesting. To harvest, the medium was aspirated and
the cells were washed once with 1X PBS and lysed with
1 ml of cold lysis buffer (10 mM Tris, pH 8, 100 mM NaCl,
0.5% DOC, 1% Triton X-100, 0.1% SDS, and 2 mM EDTA)
with a 20-m incubation on ice. The lysate was collected
and passed five times through an 18-gauge needle. An
equal portion of each cell lysate was heated to 100°C for
five minutes in Laemmli buffer (Laemmli, 1970). Proteins
were separated on 12% SDS–PAGE followed by transfer
to nitrocellulose (Towbin, 1979). The nitrocellulose was
blocked with TBS-T buffer (20 mM Tris, pH 7.6, 137 mM
NaCl, and 0.1% Tween 20) and 5% nonfat dry milk. Poly-
clonal rabbit anti-GFP serum (Clontech) was applied at
1:1000 dilution in TBS-T for 3 h. The nitrocellulose was
washed with TBS-T and goat anti-rabbit peroxidase-con-
jugated antibody (Kirkegaard & Perry Laboratories, Inc.,
Gaithersburg, MD) was applied for 1 h at a dilution of
1:2000. The nitrocellulose was washed with TBS-T and
the GFP fusion proteins visualized by applying enhanced
chemiluminescence solution followed by autoradiogra-
phy as described by the manufacturer (Amersham Life
Science, Arlington Heights, IL).
C33a cells are a cervical carcinoma cell line which do
not contain HPV sequences. C33a cells were maintained
at 37°C with 5% CO2 in DMEM high-glucose media
containing 10% fetal bovine serum, 1000 U/ml penicillin,
1 mg/ml streptomycin, and 2.5 ng/ml amphotericin B.
Cells were plated at 3 3 105 cells/ml in 35 x 10 mm tissue
culture plates containing one glass coverslip per plate.
The cells were allowed to adhere to the coverslip over-
night at 37°C and 5% CO2. Calcium phosphate transfec-
tion was performed using 5 mg of plasmid DNA (Ausubel
et al., 1989). The coverslips were recovered after 18 h,
washed with PBS, and mounted on glass slides with
Gel/Mount (Biomedia Corporation, Foster City, CA). GFP-
E1^E4 fusion proteins were detected by fluorescent mi-
croscopy at 488-nm wavelength and confocal imaging
using the Bio-Rad MC 1024 confocal microscopy imaging
system (Bio-Rad Laboratories, Hercules, CA).
T7 epitope-tagged E1^E4 protein (T7E1^E4) was ex-
pressed in C33a cells by calcium phosphate transfection
of the pcDNA3.1(1)-T7E1^E4 plasmid or cotransfection
of pcDNA3.1(1)-T7E1^E4 with the pEGFP-C1-E1^E4
plasmids. As described above, cells were grown on
glass coverslips, transfected, and the coverslips were
recovered after 18 h. The cells were then washed twice
in 1X PBS and fixed with a 1:1 solution of methanol and
acetone for 2 min at room temperature. The cells were
washed three times with 1X PBS and a 1:600 dilution of
anti-T7 monoclonal in 1X PBS plus 1% BSA was applied
to the cells. The coverslips were placed in a humidity
chamber for 3 h at room temperature. The cells were
washed three times with 1X PBS and 1:600 dilution of
either rhodamine-conjugated anti-mouse Ig (Boeh-
ringer Mannheim, Indianapolis, IN) or fluoresceine-con-
jugated affinity-purified antibody to mouse IgG (Cappel,
West Chester, PA) in 1X PBS plus 1% BSA was applied to
the cells. The coverslips were placed in a humidity
chamber at room temperature in the dark for 1 h. The
cells were washed three times with PBS and mounted
onto glass slides with Gel/Mount. T7E1^E4 and GFP
fusion proteins were detected by fluorescent microscopy
at 488- and 590-nm wavelengths. Colocalization of pro-
teins was documented by double-image photography.
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